Questions discussed in this category
For example, in patients who are HbSAg negative, anti-HBc positive and HbSAb negative, does vaccination reduce reactivation risk?
Such as patients with negative Hepatitis B surface antigen and negative viral load but with positive hepatitis b core antibody.
If so, for what platelet count threshold and do you have a preference as to which agent?
Is there a "best" way to approach treatment of the viral infection i.e concurrently with therapy, prior to therapy, delayed or post therapy? Does this...
22290199622001018504184581436963076068
Papers discussed in this category
J. Hepatol., 2019 Apr 06
Gastroenterology, 2018 May 17
Clin. Gastroenterol. Hepatol., 2018 Nov 28
Hepatology (Baltimore, Md.), 2019-10
Lancet (London, England), 2013-02-09
Hepatology (Baltimore, Md.), 2018 Apr
Clinics in liver disease, 2023 Jul 27